European Journal of Molecular & Clinical Medicine

The goal of this study was to assess the prevalence and risk factors of peripheral
neuropathy in people who had just been diagnosed with type 2 diabetes. One hundred
newly diagnosed type 2 diabetic patients were randomly selected for clinical and
electrophysiological testing to diagnose peripheral neuropathy at tertiary care in
Bhubaneswar. The Neuropathy Symptoms Score (NSS), Neuropathy Disability Score
(NDS), and Nerve Conduction Studies (NCV) were used to assess peripheral
neuropathy, and the diagnosis of peripheral neuropathy was made when two or more of
the three abnormalities of the NSS, NDS, and NCV were present. Peripheral
neuropathy affected 29 patients (29%) of the 100 newly diagnosed type 2 diabetic
patients, with 17 males (28%) and 12 females (31%). Multiple logistic regression
analysis reveals that the duration of diabetes has the greatest impact on the
development of diabetic peripheral neuropathy, although age, systolic blood pressure,
and blood glucose all play a role. Peripheral neuropathy is found to be prevalent in
newly diagnosed type 2 diabetic patients in Bhubaneswar using clinical and
electrophysiological approaches, with a significant link between peripheral neuropathy
and diabetes duration, patient age, and postprandial blood glucose levels.